CD8A and neoplasm: Thus, we chose MR (B7-H4 high) and SR (B7-H4 low) tumors, as well as FI tumors, and evaluated the protein expression of immune markers in the CD8+/cytotoxic T cell and pan-cytokeratin/tumor cell compartments using NanoString GeoMX Digital Spatial Profiling (DSP).